Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Harmony Biosciences Holdings Inc
About HRMY
Harmony Biosciences Holdings, Inc. is a pharmaceutical company. It is focused on developing and commercializing therapies for patients living with rare neurological diseases as well as patients living with other neurological diseases who have unmet medical needs. Its product, WAKIX (pitolisant), is a first-in-class molecule with a novel mechanism of action designed to enhance histamine signaling in the brain by binding to H3 receptors. WAKIX was developed for the treatment of excessive daytime sleepiness (EDS) in pediatric patients, six years and older, with narcolepsy. HBS-102, an investigational compound, which is a melanin-concentrating hormone receptor 1 (MCHR1) antagonist. ZYN002 is an investigational drug product in development for the potential treatment of behavioral symptoms associated with Fragile X syndrome (FXS) and 22q11.2 deletion syndrome (22q). It also focused on the rare epilepsy franchise in its expanding late-stage pipeline of CNS assets: EPX-100 and EPX-200.
Find out what a historical investment in Harmony Biosciences Holdings Inc would be worth today using our HRMY stock calculator.
Market Capitalisation
$1.74B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
471.15K
High today
$30.90
Low today
$29.91
Open price
$30.90
52-week high
$40.87
52-week low
$25.52
Ready to start your investing journey with Stake?
Open an accountHow do I buy HRMY shares in Australia?
Buying HRMY shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Harmony Biosciences Holdings Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in HRMY
What is the ticker symbol of Harmony Biosciences Holdings Inc?
The ticker symbol for Harmony Biosciences Holdings Inc is HRMY.
How much is one share of HRMY?
One share of HRMY is valued at $30.06 as of 16 May 2026.
What is the market capitalisation of Harmony Biosciences Holdings Inc HRMY?
As of 16 May 2026 Harmony Biosciences Holdings Inc has a market cap of $1.74B.
What is the P/E ratio of HRMY?
The Price to Earnings ratio of HRMY is 12.36.
What is the Earnings Per Share of HRMY?
The Earnings Per Share of HRMY is $2.49.
What is the 52-week high for Harmony Biosciences Holdings Inc stock?
The Harmony Biosciences Holdings Inc 52-week high stock price is $40.87.
What is the 52-week low for Harmony Biosciences Holdings Inc stock?
The Harmony Biosciences Holdings Inc 52-week low stock price is $25.52.
Can I buy HRMY shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy HRMY shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in HRMY on Stake
- Buy HRMY from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of HRMY from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
HRMY related stocks